Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2012

View Archived Issues

Novel TTK inhibitors patented by Bayer Schering Pharma

Array BioPharma synthesizes novel kinase inhibitors

Allergan patents new CCR2 receptor antagonists

Novel protein kinase inhibitors disclosed by Roche

German researchers present new GPR119 receptor agonists

Abbott designs new potential hepatitis therapies

AbOs-targeted antibodies show potential in Alzheimer's disease model

Abbott halts development of two clinical-stage candidate drugs for Alzheimer's disease

New AHA/ACC guideline update includes ticagrelor

New candidate biomarker for prostate cancer discovered

Eisai and Verastem enter research collaboration

AstraZeneca plans to evaluate ticagrelor in patients with PAD

Oncolytic virus research collaboration begins for bladder cancer

Phase II results presented on insulin analogue for diabetes

German authorities approve SkyePharma's asthma product

FDA advisory committee to discuss NDAs for Novo Nordisk insulin products

FDA approves VIVUS drug for weight management

U.S. scientists develop new model of early-onset Alzheimer's disease

Orphan medicinal product designation granted for levoglutamide

Janssen seeks U.S. and E.U. approval for Simponi

Grifols to conduct safety study of inhaled alpha1-proteinase inhibitor

Medgenics commences Israeli study of Epodure Biopumps

Isotechnika receives further funding from Canadian government

Nymox provides update on pivotal U.S. phase III trials in BPH

Antisense Therapeutics executes agreement for ATL-1102

FDA grants orphan drug status to antibody-drug conjugate in mesothelioma

Soligenix receives grant for acute radiation syndrome therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...